Welcome! Please start registering by entering your name and email address.
For those who can’t attend our live session, we’ll provide a recording.
- We will be using Zoom Webinars.
- You can join our session by using a Mac, PC or a mobile device.
Updates from EHA 2021: Promising Treatment Advances for MDS and AML
Heather Leitch, MD, St. Paul’s Hospital, Vancouver, Canada
Updates from the European Hematology Association (EHA) 2021 Virtual Congress will be presented. This webinar will provide an overview of new emerging treatments for MDS and AML patients. The latest promising clinical trials and research findings impacting the biology and treatment of MDS, and AML patients will be discussed.
The Role of Allogeneic Stem Cell Transplant in MDS
Bart L. Scott, MD, Fred Hutchinson Cancer Research Center, Seattle, Washington
This presentation will focus on reduced-intensity allogeneic stem-cell transplantation as a treatment option for MDS and describe strategies to manage treatment side effects as well as potential long-term and late effects of hematopoietic cell transplantation.
Aplastic Anemia and Myelodysplasia Association of Canada
Cindy Anthony, Executive Director, AAMAC
About AAMAC and its resources for patients, caregivers and healthcare providers will be discussed.